PRAKASH MASAND to Bipolar Disorder
This is a "connection" page, showing publications PRAKASH MASAND has written about Bipolar Disorder.
Connection Strength
1.668
-
Biological treatment of acute agitation or aggression with schizophrenia or bipolar disorder in the inpatient setting. Ann Clin Psychiatry. 2017 05; 29(2):92-107.
Score: 0.438
-
Criteria for defining symptomatic and sustained remission in bipolar I disorder: a post-hoc analysis of a 26-week aripiprazole study (study CN138-010). Psychopharmacol Bull. 2008; 41(2):12-23.
Score: 0.229
-
Differential pharmacology of atypical antipsychotics: clinical implications. Am J Health Syst Pharm. 2007 Jan 15; 64(2 Suppl 1):S3-8; quiz S24-5.
Score: 0.215
-
Metabolic and endocrine disturbances in psychiatric disorders: a multidisciplinary approach to appropriate atypical antipsychotic utilization. CNS Spectr. 2005 Oct; 10(10):suppl14 1-15.
Score: 0.196
-
Safety considerations in pharmacotherapy of bipolar disorder. CNS Spectr. 2004 Nov; 9(11 Suppl 12):16-26.
Score: 0.184
-
Cariprazine for the treatment of bipolar mania with mixed features: A post hoc pooled analysis of 3 trials. J Affect Disord. 2019 10 01; 257:600-606.
Score: 0.127
-
A 13-week, randomized double-blind, placebo-controlled, cross-over trial of ziprasidone in bipolar spectrum disorder. J Clin Psychopharmacol. 2015 Jun; 35(3):319-23.
Score: 0.096
-
A 6 week randomized double-blind placebo-controlled trial of ziprasidone for the acute depressive mixed state. PLoS One. 2012; 7(4):e34757.
Score: 0.077
-
Polypharmacy in pregnant women with major psychiatric illness: a pilot study. J Psychiatr Pract. 2007 Nov; 13(6):385-92.
Score: 0.057
-
Clinical variables associated with early administration of antipsychotics in bipolar mania. Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jan; 30(1):151-4.
Score: 0.049